|
1
|
Bellik Y, Boukraâ L, Alzahrani HA,
Bakhotmah BA, Abdellah F, Hammoudi SM and Iguer-Ouada M: Molecular
mechanism underlying anti-inflammatory and anti-allergic activities
of phytochemicals: An update. Molecules. 18:322–353. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fukai T, Satoh K, Nomura T and Sakagami H:
Antinephritis and radical scavenging activity of prenylflavonoids.
Fitoterapia. 74:720–724. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sohn HY, Son KH, Kwon CS, Kwon GS and Kang
SS: Antimicrobial and cytotoxic activity of 18 prenylated
flavonoids isolated from medicinal plants: Morus alba L., Morus
mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora
flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine.
11:666–672. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo H, Liu C, Yang L, Dong L, Wang L, Wang
Q, Li H, Zhang J, Lin P and Wang X: Morusin inhibits glioblastoma
stem cell growth in vitro and in vivo through stemness attenuation,
adipocyte transdifferentiation, and apoptosis induction. Mol
Carcinog. 55:77–89. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee JC, Won SJ, Chao CL, Wu FL, Liu HS,
Ling P, Lin CN and Su CL: Morusin induces apoptosis and suppresses
NF-kappaB activity in human colorectal cancer HT-29 cells. Biochem
Biophys Res Commun. 372:236–242. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lim SL, Park SY, Kang S, Park D, Kim SH,
Um JY, Jang HJ, Lee JH, Jeong CH, Jang JH, et al: Morusin induces
cell death through inactivating STAT3 signaling in prostate cancer
cells. Am J Cancer Res. 5:289–299. 2015.PubMed/NCBI
|
|
7
|
Lin WL, Lai DY, Lee YJ, Chen NF and Tseng
TH: Antitumor progression potential of morusin suppressing STAT3
and NFκB in human hepatoma SK-Hep1 cells. Toxicol Lett.
232:490–498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wan LZ, Ma B and Zhang YQ: Preparation of
morusin from Ramulus mori and its effects on mice with transplanted
H22 hepatocarcinoma. Biofactors. 40:636–645. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang L, Guo H, Yang L, Dong L, Lin C,
Zhang J, Lin P and Wang X: Morusin inhibits human cervical cancer
stem cell growth and migration through attenuation of NF-κB
activity and apoptosis induction. Mol Cell Biochem. 379:7–18. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim Z, Min SY, Yoon CS, Lee HJ, Lee JS,
Youn HJ, Park HK, Noh DY and Hur MH; Korean Breast Cancer Society,
: The basic facts of korean breast cancer in 2011: Results of a
nationwide survey and breast cancer registry database. J Breast
Cancer. 17:99–106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thompson A, Brennan K, Cox A, Gee J,
Harcourt D, Harris A, Harvie M, Holen I, Howell A, Nicholson R, et
al: Evaluation of the current knowledge limitations in breast
cancer research: A gap analysis. Breast Cancer Res. 10:R262008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH
and Lee JS: Prediction of cancer incidence and mortality in Korea,
2014. Cancer Res Treat. 46:124–130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park SK, Sakoda LC, Kang D, Chokkalingam
AP, Lee E, Shin HR, Ahn YO, Shin MH, Lee CW, Lee DH, et al: Rising
prostate cancer rates in South Korea. Prostate. 66:1285–1291. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei MC, Zong WX, Cheng EH, Lindsten T,
Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and
Korsmeyer SJ: Proapoptotic BAX and BAK: A requisite gateway to
mitochondrial dysfunction and death. Science. 292:727–730. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bae SI, Park JG, Kim YI and Kim WH:
Genetic alterations in gastric cancer cell lines and their original
tissues. Int J Cancer. 87:512–516. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meijerink JP, Mensink EJ, Wang K, Sedlak
TW, Slöetjes AW, de Witte T, Waksman G and Korsmeyer SJ:
Hematopoietic malignancies demonstrate loss-of-function mutations
of BAX. Blood. 91:2991–2997. 1998.PubMed/NCBI
|
|
19
|
Rampino N, Yamamoto H, Ionov Y, Li Y,
Sawai H, Reed JC and Perucho M: Somatic frameshift mutations in the
BAX gene in colon cancers of the microsatellite mutator phenotype.
Science. 275:967–969. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Altieri DC: Survivin, versatile modulation
of cell division and apoptosis in cancer. Oncogene. 22:8581–8589.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Altieri DC: Validating survivin as a
cancer therapeutic target. Nat Rev Cancer. 3:46–54. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li F, Ambrosini G, Chu EY, Plescia J,
Tognin S, Marchisio PC and Altieri DC: Control of apoptosis and
mitotic spindle checkpoint by survivin. Nature. 396:580–584. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
https://www.atcc.org/Products/All/CRL-10317.aspx#culturemethod
|
|
25
|
Park SY, Lim SL, Jang HJ, Lee JH, Um JY,
Kim SH, Ahn KS and Lee SG: Embelin induces apoptosis in human
glioma cells through inactivating NF-κB. J Pharmacol Sci.
121:192–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dandawate PR, Subramaniam D, Jensen RA and
Anant S: Targeting cancer stem cells and signaling pathways by
phytochemicals: Novel approach for breast cancer therapy. Semin
Cancer Biol. 40–41. 192–208. 2016.PubMed/NCBI
|
|
27
|
Kotecha R, Takami A and Espinoza JL:
Dietary phytochemicals and cancer chemoprevention: A review of the
clinical evidence. Oncotarget. 7:52517–52529. 2016.PubMed/NCBI
|
|
28
|
Shankar E, Kanwal R, Candamo M and Gupta
S: Dietary phytochemicals as epigenetic modifiers in cancer:
Promise and challenges. Semin Cancer Biol. 40–41. 82–99.
2016.PubMed/NCBI
|
|
29
|
Du Toit A: Cell death: Balance through a
bivalent regulator. Nat Rev Mol Cell Biol. 14:5462013. View Article : Google Scholar
|
|
30
|
Mohammad RM, Muqbil I, Lowe L, Yedjou C,
Hsu HY, Lin LT, Siegelin MD, Fimognari C, Kumar NB, Dou QP, et al:
Broad targeting of resistance to apoptosis in cancer. Semin Cancer
Biol. 35 Suppl:S78–S103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gritsko T, Williams A, Turkson J, Kaneko
S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, et al:
Persistent activation of stat3 signaling induces survivin gene
expression and confers resistance to apoptosis in human breast
cancer cells. Clin Cancer Res. 12:11–19. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nielsen M, Kaestel CG, Eriksen KW,
Woetmann A, Stokkedal T, Kaltoft K, Geisler C, Röpke C and Odum N:
Inhibition of constitutively activated Stat3 correlates with
altered Bcl-2/Bax expression and induction of apoptosis in mycosis
fungoides tumor cells. Leukemia. 13:735–738. 1999. View Article : Google Scholar : PubMed/NCBI
|
